Exploring the causes of cancer

November 23, 2015 by Anne Craig

Cells communicate with other cells in our bodies by sending and receiving signals. Cancer can occur when these signals are "dysregulated" and abnormal cells grow out of control.

In the Department of Pathology and Molecular Medicine, Queen's University researcher Mathieu Crupi studies the RET protein that is present on the surface of cells in your body and is responsible for receiving signals from outside a cell and passing on the messages within the cell. As part of a research team working with Dr. Lois Mulligan, he has identified important molecules that allow the RET protein to enter a cell and regulate its signals.

RET is a protein that plays an important role in kidney and nerve development and is also important in many human cancers including thyroid, breast and pancreas.

"Since RET has been shown to contribute to many different cancer types, understanding how active RET moves into the cell and is 'turned off' in may in future provide us with therapeutic opportunities to control its function in ," says Mr. Crupi.

"The movement of proteins from the cell surface into compartments within the cell is an important process regulating the duration and magnitude of the signals that cause cells to grow, mature or survive," says Mr. Crupi. "These movements are the key steps in controlling RET's activity and, in the future, provide answers to controlling the protein's function in cancer .

His research was supported by the Cancer Research Society and was published in a recent edition of Traffic.

Explore further: New approach in the treatment of breast cancer

More information: Traffic, onlinelibrary.wiley.com/doi/10 … 1/tra.12315/abstract

Related Stories

New approach in the treatment of breast cancer

August 8, 2013
Scientists at the MedUni Vienna, in collaboration with a working group led by Nancy Hynes at the University of Basel, have discovered a new approach in the treatment of breast cancer: an international team involving the Clinical ...

Novel oncogenic RET mutation found in small cell lung cancer

August 22, 2014
For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

Researchers identify biomarker for smoker's lung cancer

September 19, 2013
Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein—ASCL1—is associated with increased expression of the RET ...

Alternative target for breast cancer drugs

July 19, 2013
Scientists have identified higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published today ...

Researchers discover how some breast cancers alter their sensitivity to estrogen

July 27, 2011
Using human breast cancer cells and the protein that causes fireflies to glow, a Johns Hopkins team has shed light on why some breast cancer cells become resistant to the anticancer effects of the drug tamoxifen. The key ...

A new target for immuno-oncology therapies

November 16, 2015
By studying a type of immune cells, a team of researchers at the IRCM led by André Veillette, MD, identified the mechanism of action for a new target for novel immune-oncology treatments. Their discovery is published today ...

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.